Hirsutism causes: Difference between revisions
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 56: | Line 56: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" |[[11β-hydroxylase deficiency]], [[21-hydroxylase deficiency]], [[Achard-Thiers syndrome]], [[alpha-L-iduronidase deficiency]], [[Ambras syndrome]], [[Coffin-Siris syndrome]], [[congenital adrenal hyperplasia]], [[Cornelia de Lange Syndrome]], [[Hurler syndrome]], [[hypertrichosis lanuginosa]], [[Miller-Dieker syndrome]], [[nodulosis-arthropathy-osteolysis syndrome]], [[Turner syndrome]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 81: | Line 80: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" | [[Alpha-L-iduronidase deficiency]], [[cortisone reductase deficiency]], [[Hurler syndrome]], [[I-cell disease]], [[Porphyria cutanea tarda]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" |[[Ovarian cancer]], ovarian hyperthecosis, [[ovarian tumor]], [[polycystic ovary syndrome]], [[Stein-Leventhal syndrome]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" | [[Adrenal adenoma]], [[adrenal carcinoma]], [[adrenal tumor]], [[arrhenoblastoma]], [[luteoma]], [[ovarian cancer]], [[ovarian tumor]], [[pituitary tumor]], [[testicular tumor]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 115: | Line 112: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" | [[Dermatomyositis]], [[insulin resistance syndrome]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 131: | Line 128: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" | [[hirsutism|Idiopathic hirsutism]], | ||
|- | |- | ||
|} | |} |
Revision as of 15:50, 22 September 2017
Hirsutism Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Hirsutism causes On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: ; Ogheneochuko Ajari, MB.BS, MS [2] Rasam Hajiannasab M.D.[3]
Overview
The cause of hirsutism can be either an increased level of androgens (male hormones) or an oversensitivity of hair follicles to androgens, and the most common cause is polycystic ovary syndrome. Male hormones such as testosterone stimulate hair growth, increase size and intensify the pigmentation of hair. Other symptoms associated with a high level of male hormones include acne and deepening of the voice and increased muscle mass. Growing evidence implicates high circulating levels of insulin in women to the development of hirsutism. This theory is consistent with the observation that obese (and thus presumably insulin resistant hyperinsulinemic) women are at high risk of becoming hirsute. Further, treatments that lower insulin levels will lead to a reduction in hirsutism.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no known life threatening causes of hirsutism.
Common Causes
- Androgen secreting tumors
- Congenital adrenal hyperplasia
- Cushing's syndrome
- Idiopathic hirsutism
- Polycystic ovary syndrome [1]
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR (2004). "Androgen excess in women: experience with over 1000 consecutive patients". J. Clin. Endocrinol. Metab. 89 (2): 453–62. doi:10.1210/jc.2003-031122. PMID 14764747.